Predicine COVID-19 Message

This unprecedented time is especially troubling for people fighting with cancer. At Predicine, our primary focus remains our commitment to deliver genomic testing to physicians and cancer patients in need. Our global labs in San Francisco and Shanghai remain open and operational with precautionary measures put in place to ensure we are keeping our employees safe as we fulfill our responsibility to patients.

Predicine is able and committed to supporting our clients important work. Our approach to managing through this situation involves a globally coordinated response, comprehensive site preparedness, employee training and communication, and robust business continuity planning. If you have any questions about your projects or our services, please contact us here.

Predicine is proud to be an active participant in healthcare communities battling this crisis. We have contributed N95 masks to healthcare workers and other front-line responders battling the COVID-19 pandemic at healthcare institutions including Johns Hopkins University, Harvard Medical School, MSKCC, Cornell, Albert Einstein Medical College, UCSF, University of Utah, etc.. We salute all of the workers who continue to work on the front lines of the COVID-19 outbreak. Thank you for your unbound courage!

Leave a Reply

12 − 12 =